Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • gberan
    Registered Vendor
    • Sep 2013
    • 4

    #1

    Oncology Bioinformatics Post Doc, AstraZeneca, UK

    We have an exciting opportunity for an experienced computational biologist with a keen interest in next generation sequencing, genetics and drug discovery to join our Oncology Bioinformatics Group. The role holder will primarily support the EU Innovative Medicine Initiative (IMI) Oncotrack program http://www.oncotrack.eu/, an academic and industrial partnership aiming to identify and qualify biomarkers that may be used to guide patient therapy in colorectal cancer.

    The successful applicant will be a leading member of a cross pharmaceutical-academic inter-disciplinary team focusing on translational and enabling/foundation informatics. The primary goal is to apply and develop integrative informatics solutions to analyse the transcriptional, proteomic, genetic and epigenetic regulation of colon cancer patients and their matched animal and cell models, and correlate these to pharmacological response data to identify biomarkers for validation.

    The role holder will work closely with AZ Oncology Project and Disease Teams and have the opportunity to experience first hand the multidisciplinary interactions required for successful drug discovery whilst supported by the AZ global informatics community and respected academic advisors.

    This role will be based in the UK with opportunities for short term placements in Max Planck/Alacris (Berlin, Germany).

    This position is for a fixed term of 2 years with opportunity to extend to 3 years subject to satisfactory project progression.
    Key Responsibilities:
    • Lead and deliver key bioinformatics activities to support:
    o Oncotrack consortium, with critical alignment to the informatics collaborators at Max Planck and Alacris (Berlin).
    o Cross platform integrative informatics analysis of clinical and animal model data, in particular RNA-Seq, MeDIP-Seq, Exome and WGS and protein arrays.
    o Essential NGS capability build focused on extracting biological value and interpretation.
    o Reactive toolkit build to enhance access to ’omic data by science teams including potential involvement in the tranSMART translational informatics platform.
    • Work collaboratively with informatics specialists to deliver scientific information platforms, processes, tools or techniques to solve scientific problems.
    • Build expertise in and develop novel statistical/ computational methods and software tools for analyzing next-generation sequencing and high-throughput functional genomic data, including RNA-seq, DNA-seq, and large volumes of data in public repositories such as TCGA/GEO/ICGC.
    • Publish in peer-reviewed journals and present at conferences/scientific meetings.

    Eduction, Qualifications, Skills & Experience

    Essential
    • PhD level in a computational biology, bioinformatics, computer science or equivalent subject
    • Expertise in the application, analysis and interpretation of sequencing data e.g. RNA-Seq, DNA-Seq, Meth-Seq, Exome sequencing
    • Familiarity with Unix/Linux operating systems
    • Highly competent in one or more of Perl, Python, Ruby, Java, C++, R programming languages
    • Excellent communication and facilitation skills including delivery of appropriate formal or informal presentations to different scientific audiences
    • Ability to work effectively within a team to achieve collaboration objectives by contributing to discussions and disseminating knowledge and information
    • Passion for application of bioinformatics to drug discovery and delivering therapies for patients.
    • Good track record of publishing scientific research

    Desirable
    • Interdisciplinary background in bioinformatics/computational biology and cancer genomics
    • Advanced knowledge of statistical and machine learning methods
    • Bachelors degree or MSc in a Life Science, Computer Science or equivalent experience
    • Disease area and/or domain knowledge in Biological Sciences or similar
    • Experience in “big data” analysis including integration of diverse data types such as mutation, copy number and expression

    Closing Date: 8th December 2013
    Reference: IMU50
    Apply via AZ job website: http://jobs.astrazeneca.com/jobs/det...-post-doctoral

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Yesterday, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
29 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
71 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...